TMI-1 T28985
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
TMI-1, a novel orally active inhibitor of ADAM17 (TACE) and MMP, induces tumor apoptosis in a breast cancer.
CAS nr:
287403-39-8
Purity:
98%
Molecular Weight:
398,49
SMILES:
O=C([C@@H]1N(S(=O)(C2=CC=C(OCC#CC)C=C2)=O)CCSC1(C)C)NO
Formula:
C17H22N2O5S2
Pathway:
Target:
